QSP Summit

May 20-21, 2020
MIT Samberg Conference Center | 50 Memorial Dr, Cambridge, MA 02142

About the Event

qsp summit

The Quantitative Systems Pharmacology (QSP) Summit is an annual meeting dedicated to fostering an active community of industry and academic participants interested in topics relevant to QSP. In its fourth year, the QSP Summit is a free, two-day event featuring talks from key industry and academic researchers, a poster session with awards, and networking time with peers.

Call for Abstracts

Abstract submission is open to all undergraduate, graduate, postdoctoral, industry (biotechs and pharma) faculty and staff in any computational biology field, including: quantitative biology, bioinformatics, applied mathematics, biochemistry, biophysics, biomedical engineering, electrical engineering, and chemical engineering. Abstracts will be selected for either a speaking presentation or poster.

In addition, cash prizes will be awarded to the top three student, graduate student, and postdoc posters, with first place receiving $500, second place receiving $350, and third place receiving $200.

Submit an Abstract

poster session

Speakers

Subject to change.

Lindsay Avery, PhD, Principal Scientist, Sanofi
Yougan Cheng, PhD, Senior Research Investigator, Bristol-Myers Squibb
Panagiota Foteinou, PhD, Principal QSP Scientist, Sanofi
Kevin Galinsky, PhD, Senior Principal Statistician, Takeda
Sergio Iadevaia, PhD, Scientific Director; QSP, Pharmacometrics and Data Analysis, Takeda
Chanchala Kaddi, PhD, Senior Modeler, Bill & Melinda Gates Medical Research Institute
Lin Lin, PhD, Senior Scientist, Pharmacometrics, Biogen
Kathryn Miller-Jensen, PhD, Associate Professor of Biomedical Engineering, Yale University
Tatiana Novobrantseva, PhD, Co-founder and Chief Scientific Officer, Verseau Therapeutics
Ken Ogasawara, PhD, Principal Scientist, Clinical Pharmacology, Bristol-Myers Squibb
Michael Rosenblatt, MD, Chief Medical Officer, Flagship Pioneering
Anna Sher, PhD, Principal Scientist, Pfizer
Samuel Isaacson, PhD, Associate Professor of Mathematics and Statistics, Boston University
Theresa Yuraszeck, PhD, Associate Director, CSL Behring
Bo Zheng, PhD, Associate Director, Clinical Pharmacology, CSL Behring
Simon Zhou, PhD, Executive Director, Clinical Pharmacology and Translational Development, Bristol-Myers Squibb

Agenda

Subject to change.

Day 1 | May 20, 2020
Day 2 | May 21, 2020

09:00 AM	Registration and breakfast
09:30 AM	John Burke, PhD Co-Founder, President & CEO, Applied BioMath Opening remarks
09:45 AM	Michael Rosenblatt, MD Chief Medical Officer, Flagship Pioneering
10:15 AM	Samuel Isaacson, PhD Associate Professor of Mathematics and Statistics, Boston University
10:45 AM	Break and poster viewing session
11:45 AM	Sergio Iadevaia, PhD Scientific Director, QSP, Pharmacometrics and Data Analysis, Takeda
12:15 PM	Kathryn Miller-Jensen, PhD Associate Professor of Biomedical Engineering, Yale University
12:45 PM	Lunch and poster viewing session
02:15 PM	Panagiota Foteinou, PhD Principal QSP Scientist, Sanofi
02:45 PM	Lightning talks
03:15 PM	Break and poster viewing session
04:15 PM	Lindsay Avery, PhD Principal Scientist, Sanofi
04:45 PM	Yougan Cheng, PhD Senior Research Investigator, Bristol-Myers Squibb
05:00 PM	Coffee and tea break
05:15 PM	Theresa Yuraszeck, PhD Associate Director, CSL Behring Bo Zheng, PhD Associate Director, Clinical Pharmacology, CSL Behring
05:45 PM	Closing remarks - Day 1 concludes

09:00 AM	Registration and breakfast
09:30 AM	John Burke, PhD Co-Founder, President & CEO, Applied BioMath Opening remarks
09:45 AM	Lin Lin, PhD Senior Scientist, Pharmacometrics, Biogen
10:15 AM	Simon Zhou, PhD Executive Director, Clinical Pharmacology and Translational Development, Bristol-Myers Squibb Ken Ogasawara, PhD Principal Scientist, Clinical Pharmacology, Bristol-Myers Squibb
10:45 AM	Break and poster viewing session
11:45 AM	Chanchala Kaddi, PhD Senior Modeler, Bill & Melinda Gates Medical Research Institute
12:15 PM	Kevin Galinsky, PhD Senior Principal Statistician, Takeda
12:45 PM	Lunch and poster awards
01:45 PM	Anna Sher, PhD Principal Scientist, Pfizer
02:15 PM	Tatiana Novobrantseva, PhD Co-founder and Chief Scientific Officer, Verseau Therapetuics
02:45 PM	Closing remarks - Day 2 concludes

Register

Questions?

Contact Renee at rfisher@appliedbiomath.com.